Login / Signup

Challenges and Opportunities: Using Omics to Generate Testable Insights Into Pathogenic Mechanisms in Preclinical Seropositive Rheumatoid Arthritis.

V Michael Holers
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2020)
Keyphrases
  • rheumatoid arthritis
  • disease activity
  • single cell
  • cell therapy
  • interstitial lung disease
  • ankylosing spondylitis
  • stem cells
  • systemic lupus erythematosus
  • idiopathic pulmonary fibrosis
  • bone marrow